Chromosomal instability syndromes are sensitive to poly ADP-ribose polymerase inhibitors

Terry J Gaymes1, Sydney Shall, Farzin Farzaneh

  • 1Department of Haematological Medicine, Leukaemia Sciences Laboratories, The Rayne Institute, Kings College London, Denmark Hill Campus, London, UK.

Haematologica
|October 8, 2008
PubMed

Insights

Poly ADP-ribose polymerase (PARP) inhibitors induce cancer cell death by targeting DNA repair defects. This study shows PARP inhibitors are effective against cells with various DNA repair deficiencies, expanding their therapeutic potential.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Genetics

Background:

  • Poly ADP-ribose polymerase (PARP) inhibitors are known to target cancer cells with homologous recombination DNA repair defects.
  • Chromosomal instability disorders like Fanconi Anemia and Bloom's syndrome exhibit DNA repair dysfunction and are prone to leukemic transformation.

Purpose of the Study:

  • To investigate the efficacy of PARP inhibitors in cells with DNA repair defects beyond homologous recombination.
  • To explore the impact of PARP inhibitors on DNA repair pathways, including non-homologous end joining.

Main Methods:

  • Treatment of Fanconi Anemia, Bloom's syndrome cells, and ATM(-/-)/NBS(-/-) fibroblasts with PARP inhibitors.
  • Assessment of apoptosis induction via cell viability assays.
  • Immunocytochemistry to evaluate homologous recombination and non-homologous end joining activity.

Main Results:

  • PARP inhibitors induced significant apoptosis in Fanconi Anemia, Bloom's syndrome cells, and ATM(-/-)/NBS(-/-) fibroblasts.
  • Homologous recombination was abrogated or compromised in NBS(-/-), ATM(-/-), and Fanconi anemia cells, but normal in Bloom's syndrome cells upon PARP inhibition.
  • PARP inhibitors increased non-homologous end joining activity, and cells deficient in this pathway showed extreme sensitivity.

Conclusions:

  • PARP inhibitors demonstrate efficacy against a broader range of DNA repair and signaling defects, not limited to homologous recombination.
  • These findings suggest an expanded therapeutic window for PARP inhibitors in various cancer types with distinct DNA repair deficiencies.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair01:08

Nucleotide Excision Repair

Overview
Spontaneous and Induced Mutations01:30

Spontaneous and Induced Mutations

Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).